Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 18 | 2017 | 310 | 1.870 |
Why?
|
| Breast Neoplasms | 16 | 2017 | 1533 | 1.110 |
Why?
|
| Radiographic Image Enhancement | 7 | 2010 | 208 | 0.490 |
Why?
|
| Breast Diseases | 3 | 2016 | 40 | 0.380 |
Why?
|
| Liquid Crystals | 1 | 2006 | 4 | 0.300 |
Why?
|
| Breast Density | 2 | 2017 | 21 | 0.290 |
Why?
|
| Data Display | 1 | 2006 | 17 | 0.290 |
Why?
|
| Computers, Handheld | 1 | 2005 | 44 | 0.270 |
Why?
|
| Radiology | 3 | 2017 | 97 | 0.260 |
Why?
|
| Mass Screening | 4 | 2017 | 837 | 0.240 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 424 | 0.240 |
Why?
|
| Ultrasonography, Mammary | 1 | 2003 | 39 | 0.230 |
Why?
|
| Sensitivity and Specificity | 10 | 2016 | 1753 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2015 | 2222 | 0.210 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2002 | 52 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 772 | 0.210 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 848 | 0.200 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 766 | 0.200 |
Why?
|
| Paranasal Sinuses | 1 | 2002 | 165 | 0.190 |
Why?
|
| Breast | 2 | 2015 | 137 | 0.180 |
Why?
|
| Endoscopy | 1 | 2002 | 464 | 0.170 |
Why?
|
| X-Ray Film | 2 | 2010 | 16 | 0.170 |
Why?
|
| Observer Variation | 5 | 2016 | 330 | 0.170 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2010 | 61 | 0.160 |
Why?
|
| Mobile Health Units | 1 | 2017 | 18 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2016 | 237 | 0.150 |
Why?
|
| Sinusitis | 1 | 2002 | 432 | 0.150 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 177 | 0.130 |
Why?
|
| Quality Control | 2 | 2005 | 81 | 0.130 |
Why?
|
| User-Computer Interface | 2 | 2006 | 230 | 0.130 |
Why?
|
| Female | 16 | 2017 | 38015 | 0.120 |
Why?
|
| Humans | 21 | 2017 | 68525 | 0.120 |
Why?
|
| Telemedicine | 1 | 2002 | 699 | 0.120 |
Why?
|
| North Carolina | 4 | 2010 | 224 | 0.120 |
Why?
|
| Middle Aged | 13 | 2017 | 21119 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 503 | 0.110 |
Why?
|
| Mastectomy, Segmental | 3 | 2010 | 63 | 0.100 |
Why?
|
| Mastectomy | 1 | 2011 | 56 | 0.100 |
Why?
|
| Calcinosis | 2 | 2016 | 241 | 0.100 |
Why?
|
| Time and Motion Studies | 1 | 2010 | 16 | 0.090 |
Why?
|
| Task Performance and Analysis | 2 | 2010 | 150 | 0.090 |
Why?
|
| Reproducibility of Results | 6 | 2016 | 2077 | 0.090 |
Why?
|
| Workflow | 1 | 2010 | 100 | 0.090 |
Why?
|
| Professional Competence | 1 | 2010 | 100 | 0.090 |
Why?
|
| X-Ray Diffraction | 1 | 2009 | 53 | 0.090 |
Why?
|
| Equipment Design | 2 | 2009 | 500 | 0.080 |
Why?
|
| Aged, 80 and over | 7 | 2016 | 4843 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 444 | 0.080 |
Why?
|
| Research Design | 2 | 2017 | 729 | 0.080 |
Why?
|
| Aged | 9 | 2017 | 14842 | 0.080 |
Why?
|
| Adult | 9 | 2017 | 21375 | 0.080 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2005 | 16 | 0.070 |
Why?
|
| Receptor, ErbB-2 | 1 | 2006 | 128 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2011 | 3256 | 0.060 |
Why?
|
| Carcinoma | 1 | 2006 | 215 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 1 | 2004 | 104 | 0.060 |
Why?
|
| Annual Reports as Topic | 1 | 2004 | 12 | 0.060 |
Why?
|
| Lymphatic Metastasis | 1 | 2004 | 274 | 0.060 |
Why?
|
| Monte Carlo Method | 1 | 2004 | 124 | 0.060 |
Why?
|
| United States Food and Drug Administration | 1 | 2004 | 131 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2006 | 2004 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2004 | 239 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2006 | 705 | 0.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2005 | 373 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2006 | 508 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2005 | 229 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2003 | 75 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2002 | 85 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 689 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2006 | 657 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2004 | 419 | 0.050 |
Why?
|
| Radiotherapy Dosage | 2 | 2011 | 125 | 0.050 |
Why?
|
| ROC Curve | 2 | 2015 | 392 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1139 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2011 | 7028 | 0.040 |
Why?
|
| Intraoperative Period | 2 | 2010 | 62 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 2798 | 0.040 |
Why?
|
| United States | 2 | 2016 | 7335 | 0.040 |
Why?
|
| Equipment Failure Analysis | 2 | 2009 | 121 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 1851 | 0.040 |
Why?
|
| Risk Factors | 3 | 2017 | 5719 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2016 | 83 | 0.040 |
Why?
|
| Premenopause | 1 | 2016 | 57 | 0.040 |
Why?
|
| Postmenopause | 1 | 2016 | 92 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2016 | 110 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 122 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 539 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2016 | 284 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 2323 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 439 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1465 | 0.030 |
Why?
|
| Prognosis | 2 | 2006 | 2093 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2011 | 125 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2011 | 91 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2010 | 132 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 799 | 0.020 |
Why?
|
| Survival Rate | 1 | 2011 | 1055 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 453 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 951 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 737 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 378 | 0.020 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2007 | 53 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2006 | 219 | 0.020 |
Why?
|
| Age Distribution | 1 | 2006 | 319 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 1419 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 1341 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 7264 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 652 | 0.020 |
Why?
|
| Male | 2 | 2006 | 37281 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2005 | 189 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 307 | 0.020 |
Why?
|
| Linear Models | 1 | 2005 | 521 | 0.010 |
Why?
|
| Incidence | 1 | 2006 | 1582 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2010 | 3702 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 1609 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 1194 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 5708 | 0.010 |
Why?
|